feed,title,long_url,short_url
Benzinga,"Global Respiratory Virus Infection Drugs Market to Flourish at 7% CAGR, Crossing US$ 82.8 Billion by 2030: TMR Report",https://benzinga.com/pressreleases/23/06/g32686382/global-respiratory-virus-infection-drugs-market-to-flourish-at-7-cagr-crossing-us-82-8-billion-by-,
